-
InformationiCFO Information Booth How can we help?
-
EntrepreneurWibly Visual Learning Platform for Knowledge Networks
-
EntrepreneurInfinityBit InfinityBit: A New Era of Transparent Trading
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
EntrepreneurSmart Soda A new standard in wellness beverages for offices, c-stores, healthcare, education and restaurants.
-
EntrepreneurCommerceBlitz
-
EntrepreneurPerioSciences
-
EntrepreneurRICOVR Rapid Saliva Testing For Biomarkers
-
EntrepreneurAddimmune Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
-
EntrepreneurUbiq
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Gaytri Kachroo!
Join us next time to meet Gaytri Kachroo!
About Arise BioPharma
Arise BioPharma Inc. (Arise) is a wholly owned subsidiary of Peptide Account LLC. Arise holds property rights to several late stage compounds targeting neuro-degenerative illnesses. It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.